Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Health & Fitness
Sports
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/94/34/fd/9434fd45-88da-7db2-3fdc-d824abde4d7c/mza_12640165207936048558.jpg/600x600bb.jpg
The NFX Podcast
NFX
172 episodes
1 month ago
We believe creating something of true significance starts with seeing things others do not. NFX is a venture firm exclusively focused on pre-seed & seed stage startups.
Show more...
Technology
Business,
Investing
RSS
All content for The NFX Podcast is the property of NFX and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
We believe creating something of true significance starts with seeing things others do not. NFX is a venture firm exclusively focused on pre-seed & seed stage startups.
Show more...
Technology
Business,
Investing
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/94/34/fd/9434fd45-88da-7db2-3fdc-d824abde4d7c/mza_12640165207936048558.jpg/600x600bb.jpg
The Past, Present, and Future of Longevity w/ Joe Betts-LaCroix Alex Colville
The NFX Podcast
38 minutes 19 seconds
1 year ago
The Past, Present, and Future of Longevity w/ Joe Betts-LaCroix Alex Colville
In this episode, Omri Amirav-Drory (NFX), Joe Betts-LaCroix (Retro Bio), and Alex Colville (Age1) discuss the history, recent progress, and hurdles in the longevity industry, including the evaluation of potential founders and business risks. The discussion further encompasses the global fundraising potential and societal impact of the longevity sector, viewing aging as a disease, and the future of longevity drugs. Learn more at - https://nfx.com/bio
The NFX Podcast
We believe creating something of true significance starts with seeing things others do not. NFX is a venture firm exclusively focused on pre-seed & seed stage startups.